Published in Pharma and Healthcare category by MBA Skool Team
Lupin is one of the leading brands in the pharma and healthcare sector. Lupin SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of Lupin:
World wide leader in Cephalosporin and Anti TB drugs
Considerable presence in market for drugs against Asthma, Pediatrics, Diabetes, and CNS boosts the sales
In the US and Japanese market it is the largest generic player
Acquisition of I’rom pharma helped to increase its product list and in turn sales
Wide global footprint as it is present in over 70 countries
Above are the strengths in the SWOT Analysis of Lupin. The strengths of Lupin looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
High dependence on global formulation business with 84% revenue coming from US market
Forecasting done on technological level is less
It operates in low growth segments such CNS, respiratory diseases
These were the weaknesses in the Lupin SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
It is innovation led pharmaceutical company, which specializes in generic, API & branded formulations for developed & developing world.
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Browse marketing analysis of more brands and companies similar to Lupin. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way. Edit the brand or add a new one to SWOT Analysis section : Contribute